Gsa Capital Partners LLP Nektar Therapeutics Transaction History

Gsa Capital Partners LLP

$1.19 Billion
Q1 2024

A detailed history of Gsa Capital Partners LLP transactions in Nektar Therapeutics stock. As of the latest transaction made, Gsa Capital Partners LLP holds 1,989,905 shares of NKTR stock, worth $2.47 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,989,905

Previous 5,255,790 62.14%

Holding current value

$2.47 Million

Previous $2.94 Million 37.14%

% of portfolio

0.15%

Previous 0.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$0.49 - $0.96 $1.6 Million - $3.14 Million	-3,265,885 Reduced 62.14%	1,989,905 $1.85 Million
Q4 2023 Feb 16, 2024	BUY	$0.42 - $0.57 $1.43 Million - $1.95 Million	3,414,712 Added 185.47%	5,255,790 $2.94 Million
Q3 2023 Nov 15, 2023	BUY	$0.51 - $1.05 $847,920 - $1.75 Million	1,662,589 Added 931.48%	1,841,078 $1.1 Million
Q2 2023 Aug 14, 2023	SELL	$0.53 - $1.03 $993 - $1,930	-1,874 Reduced 1.04%	178,489 $103,000
Q1 2023 May 12, 2023	SELL	$0.64 - $3.15 $297,390 - $1.46 Million	-464,672 Reduced 72.04%	180,363 $126,000

Q4 2022 Feb 13, 2023	BUY	$2.03 - $4.28 $1.19 Million - $2.51 Million	585,748 Added 987.99%	645,035 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $57,337 - $96,945	18,861 Added 46.66%	59,287 $190,000
Q2 2022 Aug 09, 2022	BUY	$3.17 - $6.17 $128,150 - $249,428	40,426 New	40,426 $154,000
Q1 2022 May 11, 2022	SELL	$4.16 - $13.72 $43,792 - $144,430	-10,527 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $130,566 - $221,950	-12,056 Reduced 53.39%	10,527 $142,000
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $850,543 - $1.23 Million	-65,076 Reduced 74.24%	22,583 $406,000
Q2 2021 Aug 05, 2021	BUY	$16.52 - $20.4 $1.45 Million - $1.79 Million	87,659 New	87,659 $1.5 Million
Q4 2020 Feb 03, 2021	SELL	$15.77 - $19.03 $471,664 - $569,168	-29,909 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$16.59 - $24.79 $496,190 - $741,444	29,909 New	29,909 $496,000
Q4 2018 Feb 12, 2019	SELL	$30.43 - $56.65 $478,876 - $891,501	-15,737 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$46.46 - $68.49 $39,444 - $58,148	-849 Reduced 5.12%	15,737 $959,000
Q2 2018 Aug 09, 2018	BUY	$46.25 - $104.45 $767,102 - $1.73 Million	16,586 New	16,586 $810,000
Q1 2018 May 11, 2018	SELL	$57.4 - $108.44 $817,146 - $1.54 Million	-14,236 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $1.07 Million - $2.8 Million	-46,362 Reduced 76.51%	14,236 $850,000
Q3 2017 Nov 20, 2017	BUY	$17.79 - $24.0 $1.08 Million - $1.45 Million	60,598	60,598 $1.45 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $232M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Nektar Therapeutics Transaction History